Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Chem Inf Model ; 46(2): 863-75, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16563018

RESUMEN

Proton nuclear magnetic resonance (1H NMR) spectroscopic analysis of mixtures has been used extensively for a variety of applications ranging from the analysis of plant extracts, wine, and food to the evaluation of toxicity in animals. For example, NMR analysis of urine samples has been used extensively for biomarker discovery and, more simply, for the construction of classification models of toxicity, disease, and biochemical phenotype. However, NMR spectra of complex mixtures typically show unwanted local peak shifts caused by matrix and instrument variability, which must be compensated for prior to statistical analysis and interpretation of the data. One approach is to align the spectral peaks across the data set. An efficient and fast warping algorithm is required as the signals typically contain ca. 32,000-64,000 data points and there can be several thousand spectra in a data set. As demonstrated in our study, the iterative fuzzy warping algorithm fulfills these requirements and can be used on-line for an alignment of the NMR spectra. Correlation coefficients between the aligned and target spectra are used as the evaluation function for the algorithm, and its performance is compared with those of other published warping methods.


Asunto(s)
Algoritmos , Lógica Difusa , Espectroscopía de Resonancia Magnética/métodos , Urinálisis/métodos , Animales , Masculino , Protones , Ratas , Ratas Sprague-Dawley , Reproducibilidad de los Resultados , Urinálisis/instrumentación
2.
Drug Discov Today Technol ; 2(3): 197-204, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-24981936

RESUMEN

Genomic and proteomic platform data constitute a hugely important resource to current efforts in disease understanding, systems biology and drug discovery. We review prerequisites for the adequate management of 'omic' data, the means by which such data are analyzed and converted to knowledge relevant to drug discovery and issues crucial to the integration of such data, particularly with chemical, genetic and clinical data.:

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA